New stent shows promise for blocked brain arteries
NCT ID NCT05316311
First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study tested a special stent designed to open severely narrowed brain arteries in 194 people with symptomatic intracranial atherosclerosis. The goal was to see if the stent is safe and effective at keeping arteries open for at least 12 months. Researchers measured how often the artery narrowed again inside the stent and whether the procedure was technically successful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CERENOVUS ENTERPRISE 2 intracranial stent
- What this could lead to
- If successful, this stent could offer a safe way to reopen blocked brain arteries and reduce stroke risk in high-risk patients.
- What could go wrong
- This was a single-arm study without a comparison group, so results may not prove the stent is better than standard care. The stent may also narrow again over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Central Hospital Affiliated to Shandong First Medical University (Jinan Central Hospital)
Jinan, China
-
First Affiliated Hospital, Harbin Medical University
Harbin, China
-
Haikou People's Hospital
Haikou, China
-
Huashan Hospital Fudan University
Shanghai, China
-
Nanjing Drum Tower Hospital
Nanjing, China
-
Ningbo First Hospital
Ningbo, China
-
Qilu Hospital of Shandong University
Jinan, China
-
Shandong Provincial Hospital
Jinan, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
Wenzhou Central Hospital
Wenzhou, China
-
West China Hospital of Sichuan University
Chengdu, China
-
Xuanwu Hospital, Capital Medical University
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Cholesterol-Lowering shot reverse brain artery blockages?
- New MRI technique could help predict strokes in High-Risk patients
- New drug combo aims to stop repeat strokes in High-Risk patients
- New brain stent aims to stop strokes in High-Risk patients
- Could a diabetes drug shield your brain from stroke?
- Stenting may offer new hope for tough stroke cases